The majority of pancreatic neuroendocrine tumors showed CHGA positive immunostaining, and primary tumors with metastases revealed significantly less CHGA protein expression than primary tumors without metastases [21]. This evidence concerns the gene CHGA and neuroendocrine neoplasm.